- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07941297
Virtual Reality-Based Cognitive-Motor Rehabilitation in Traumatic Brain Injury
Novel Virtual Reality-Based Cognitive-Motor Rehabilitation for Individuals With Traumatic Brain Injury
This study aims to evaluate the feasibility, safety, and efficacy of a novel virtual reality (VR)-based cognitive-motor rehabilitation program for individuals with traumatic brain injury (TBI). The intervention uses the Virtual Reality Color Trails Test (VR-CTT), which combines cognitive tasks with upper-limb movements in an immersive virtual environment.
The study consists of two stages. The first stage is a feasibility pilot involving 15 participants who will complete three VR training sessions over one week. The second stage is a randomized controlled trial involving 80 participants allocated to either VR-CTT training combined with standard rehabilitation or a control group receiving standard rehabilitation with additional therapy time. The intervention will consist of nine sessions over three weeks.
The study will assess feasibility, safety, executive functions, upper-limb motor performance, balance, and functional outcomes.
Study Overview
Status
Conditions
Detailed Description
Traumatic brain injury (TBI) frequently results in cognitive and motor impairments that affect everyday functioning. Conventional rehabilitation often addresses these domains separately, although many daily activities require their simultaneous integration. This study evaluates a rehabilitation approach based on the Virtual Reality Color Trails Test (VR-CTT), an immersive system developed at Sheba Medical Center that combines cognitive challenges with coordinated head and upper-limb movements.
The study consists of two sequential stages.
**Stage 1: Feasibility Pilot**
Fifteen participants with TBI will receive three VR-CTT training sessions over one week in addition to standard rehabilitation. Training will progress from seated tasks to more challenging standing activities according to individual abilities. This stage will assess feasibility, safety, usability, and participant satisfaction to inform implementation of the subsequent trial.
**Stage 2: Randomized Controlled Trial**
Eighty participants with TBI will be randomly assigned in a 1:1 ratio to two parallel groups. The intervention group will receive standard rehabilitation supplemented by nine VR-CTT training sessions over three weeks. Training difficulty will increase progressively through changes in cognitive demands, the number of targets, body position, and unilateral or bilateral hand use.
The control group will receive standard rehabilitation supplemented by additional cognitive or motor therapy to match the total treatment time of the intervention group.
Outcome assessments will be conducted before and after the intervention period and will include measures of executive functioning, upper-limb motor performance, balance, everyday functioning, and cognitive-motor interaction. Outcome assessors will remain blinded to group allocation during the randomized stage.
The study aims to determine whether integrated VR-based cognitive-motor training is feasible and safe and whether it improves cognitive and motor outcomes compared with conventional rehabilitation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Amihai Gottlieb, Ph.D
- Phone Number: +972543323180
- Email: amihai.gottlieb@gmail.com
Study Locations
-
-
-
Ramat Gan, Israel
- Sheba Medical Center
-
Contact:
- Amihai Gottlieb, Ph.D
- Phone Number: +972543323180
- Email: amihai.gottlieb@gmail.com
-
Sub-Investigator:
- Meir Plotnik, Prof.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
**Inclusion Criteria:**
- Men and women aged 18-50 years.
- Admitted for inpatient rehabilitation following traumatic brain injury (TBI).
- Glasgow Coma Scale (GCS) score of 9-15 at admission.
- Brain CT positive for acute intracranial trauma (including complicated mild or moderate TBI).
- Presence of cognitive and motor symptoms as determined by clinical evaluation.
- Sufficient decision-making capacity to provide informed consent.
**Exclusion Criteria:**
- Inability to meaningfully comprehend the study procedures (e.g., severe aphasia or cognitive impairment), as determined through a structured capacity assessment.
- Severe physical limitations that prevent the use of VR equipment (e.g., severe upper-limb fractures preventing controller use).
- History of epilepsy or seizures triggered by flashing lights.
- Severe visual or vestibular impairments that would make VR exposure unsafe (e.g., severe vertigo).
- Active psychiatric conditions (e.g., acute psychosis) likely to interfere with adherence to study procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stage 1: VR-CTT Feasibility Pilot
Fifteen participants with traumatic brain injury will receive standard rehabilitation supplemented by three VR-CTT training sessions over one week. Sessions will last approximately 45 minutes and progress from seated activities to standing activities according to participants' abilities. This stage will evaluate feasibility, safety, and usability. |
An immersive virtual reality-based cognitive-motor rehabilitation program using the HTC VIVE system and custom-developed VR-CTT software. Participants perform cognitive tasks involving visual search, attention, and cognitive flexibility while reaching toward virtual targets using coordinated upper-limb and head movements. Training difficulty is progressively adjusted by modifying the number of targets, cognitive demands, posture, and hand use. The intervention consists of three sessions over one week in Stage 1 and nine sessions over three weeks in Stage 2. |
|
Experimental: Stage 2: VR-CTT Training
Forty participants will receive standard inpatient rehabilitation supplemented by nine VR-CTT training sessions over three weeks (three sessions per week, approximately 45 minutes each). Training will progressively increase cognitive and motor demands through changes in target number, task complexity, posture, and hand use. |
An immersive virtual reality-based cognitive-motor rehabilitation program using the HTC VIVE system and custom-developed VR-CTT software. Participants perform cognitive tasks involving visual search, attention, and cognitive flexibility while reaching toward virtual targets using coordinated upper-limb and head movements. Training difficulty is progressively adjusted by modifying the number of targets, cognitive demands, posture, and hand use. The intervention consists of three sessions over one week in Stage 1 and nine sessions over three weeks in Stage 2. |
|
Active Comparator: Stage 2: Active Control
Forty participants will receive standard inpatient rehabilitation supplemented by approximately three hours per week of additional cognitive or motor therapy with a therapist or volunteer, without VR-CTT training. The additional therapy is intended to match the total treatment time of the intervention group. |
Additional cognitive or motor rehabilitation exercises administered by a therapist or volunteer, supplementing standard inpatient rehabilitation. Participants receive approximately three hours of additional therapy per week over three weeks to match the total treatment time provided to the VR-CTT intervention group. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Executive Function Composite Score
Time Frame: Baseline (Week 0) and post-intervention (Week 4).
|
Change in executive functioning assessed using a composite score derived from the Stroop Test, Rule Shift Cards Test (BADS), and Montreal Cognitive Assessment (MoCA). Standardized scores will be used to evaluate changes in executive control, including inhibition, cognitive shifting, and mental flexibility. |
Baseline (Week 0) and post-intervention (Week 4).
|
|
Change in Upper Limb Motor Function (ARAT)
Time Frame: Baseline (Week 0) and post-intervention (Week 4).
|
Change in upper limb motor function assessed using the Action Research Arm Test (ARAT), which evaluates upper extremity motor performance and coordination. Higher scores indicate better motor function. |
Baseline (Week 0) and post-intervention (Week 4).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Functional Status (FSE)
Time Frame: Baseline (Week 0) and post-intervention (Week 4).
|
Change in everyday functional outcomes assessed using the Functional Status Examination (FSE), which evaluates functional limitations following traumatic brain injury. |
Baseline (Week 0) and post-intervention (Week 4).
|
|
Change in Balance (Berg Balance Scale)
Time Frame: Baseline (Week 0) and post-intervention (Week 4).
|
Change in static and dynamic balance assessed using the Berg Balance Scale (BBS). Higher scores indicate better balance performance. |
Baseline (Week 0) and post-intervention (Week 4).
|
|
Change in Cognitive-Motor Performance (VR Supermarket Task)
Time Frame: Baseline (Week 0) and post-intervention (Week 4).
|
Change in performance on a virtual reality-based supermarket task assessing cognitive-motor integration, including divided attention and sustained attention during simulated everyday activities. |
Baseline (Week 0) and post-intervention (Week 4).
|
|
Change in Dual-Task Performance (Box and Block Test)
Time Frame: Baseline (Week 0) and post-intervention (Week 4).
|
Change in dual-task performance assessed using the Dual-Task Box and Block Test (BBT-DT), in which participants transfer blocks while simultaneously performing mental arithmetic. |
Baseline (Week 0) and post-intervention (Week 4).
|
|
Feasibility of VR-CTT Training
Time Frame: During the one-week pilot intervention (Stage 1).
|
Feasibility assessed by adherence to the planned VR-CTT training protocol, including the proportion of scheduled training sessions completed by participants. |
During the one-week pilot intervention (Stage 1).
|
|
Simulator Sickness Symptoms
Time Frame: After each VR training session during the one-week pilot (Stage 1).
|
Simulator sickness symptoms, including nausea, dizziness, headache, and eyestrain, assessed after VR training sessions using the Simulator Sickness Questionnaire (SSQ). |
After each VR training session during the one-week pilot (Stage 1).
|
|
VR-CTT Usability and Participant Satisfaction
Time Frame: At completion of the one-week pilot intervention (Stage 1).
|
Usability and participant satisfaction with the VR-CTT system assessed using post-training feedback questionnaires addressing comfort, ease of use, and overall experience. |
At completion of the one-week pilot intervention (Stage 1).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHEBA-26-3045-GZ-CTIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.